Skip to content

Iovate taps Wes Parris as new CEO

Iovate Health Sciences International has announced that Tim Toll, its chief executive officer, is retiring after nearly four years with the company and will transition to serving on the board as an advisory director.

Table of Contents

OAKVILLE, Ontario—Iovate Health Sciences International has announced that Tim Toll, its chief executive officer, is retiring after nearly four years with the company and will transition to serving on the board as an advisory director. The company has hired nutrition industry veteran Wes Parris to assume the role of CEO, effective April 29. The duo is working together to help ensure a seamless handoff, the company said.

Parris brings over a decade of successful chief executive officer experience within the health and wellness industry. Over the last four years, as President, Chief Executive Officer, and Board Director of PanTheryx, he established the company as the world’s largest Bovine Colostrum producer and led the company’s successful expansion into consumer brands – including the acquisition and global expansion of the TruBiotics probiotic brand.

Prior to PanTheryx, as president and CEO of I-Health, Inc., Parris led all operations including sales, marketing, research and development, finance, and business development. During his almost 13 years with the company, he established and grew a category-leading consumer brand portfolio. These brands include Culturelle (a leading global probiotic brand), AZO® (the #1 global over-the-counter (OTC) urinary health brand), Estroven (the #1 global menopause symptom relief brand) and Ovega-3 (a leading brand in the vegetarian omega 3 category).

Before his tenure at i-Health, Parris held leadership positions at several major consumer products companies including Energizer, Quaker Oats (Gatorade) and Procter & Gamble.

“I am thrilled to join the Iovate team at such a transformative and promising time for the company,” Parris said. “I look forward to accelerating the delivery of category leading innovation, scientific expertise, and our unwavering commitment to provide high quality products that support the optimal health and well-being of consumers.”

Parris will report to Michael Liu, managing director of Xiwang Iovate Health Sciences Inc. and Iovate’s executive vice chairman of the board.

“We are very excited to welcome Wes into the Xiwang Iovate family,” Liu said. “Wes’ extensive experience and proven track record as a transformative CEO and seasoned operator will be key to Iovate’s growth and future success.”

Comments

Latest